Jennewein Biotechnologie GmbH

Jennewein Biotechnologie is a leading international industrial biotechnology company with a range of products in the field of complex oligosaccharides (HMOs) and rare monosaccharides. The company manufactures an extensive portfolio of innovative HMO products, such as 2′ fucosyllactose, 3′-fucosyllactose and lacto-N-tetraose. These rare sugars are used in the food industry (particularly infant milk formulas), the pharmaceutical industry, and the cosmetic industry. The manufacturing process involves state-of-the-art fermentation techniques. In 2015, the US Food and Drug Administration (FDA) granted Jennewein Biotechnologie a license to market 2′-fucosyllactose in the USA. This was followed in 2017 by European Union authorisation under the Novel Food Regulation.

Gut bacteria influences our health from birth onwards

The Role Of Fucosylated And Sialylated Human Milk Oligosaccharides In Infant Nutrition

A way to combat norovirus?

Can human milk oligosaccharides modulate autoimmune diseases?

Human milk oligosaccharides during pregnancy

Artificial HMOs mimic mothers’ secret formula

Breast milk sugars can protect babies from deadly diarrhoea

Dairy – In-Depth Focus 2019

Sugars from human milk – a secret weapon against allergies?

Human milk oligosaccharides, a success story

Jennewein Biotechnologie and Yili Group join forces in China